{"@odata.context":"https://open.ejn.gov.ba/$metadata#Awards","value":[{"Id":1341328,"LotName":"INN infliksimab (REMICADE), infuzija 100 mg","Value":501608.10,"ContractDate":"2016-01-25T23:00:00Z","ContractingAuthorityId":47196,"ContractingAuthorityName":"ZAVOD ZDRAVSTVENOG OSIGURANJA I REOSIGURANJA FEDERACIJE BOSNE I HERCEGOVINE","ContractingAuthorityTaxNumber":"4200642000008","ContractingAuthorityCityName":"NOVO SARAJEVO","ContractingAuthorityType":"PublicEntity","ContractingAuthorityActivityTypeName":"Zdravstvo","ContractingAuthorityAdministrativeUnitType":"Entity","ContractingAuthorityAdministrativeUnitName":"Federacija Bosne i Hercegovine","ProcedureId":1140936,"ProcedureName":"Remicade (INN infliksimab), infuzija 100 mg i Humira (INN adalimumab), injekcija 40 mg","ProcedureNumber":"804-4-1-8/16","ProcedureType":"NegotiatedProcedureWithoutProcurementNotice","ContractType":"Goods","ContractCategoryName":"Kupovina","ContractSubcategoryName":null,"HasLots":true,"IsAuctionOnline":false,"IsMasterAgreement":false,"IsDefenseAndSecurity":false,"IsJointProcurement":false,"IsOnBehalfProcurement":false,"AwardCriterion":"LowestPrice","NoticeId":44053,"NoticeNumber":"804-4-1-8-5-10/16","AdditionalInformation":null,"AllowedSubcontracting":false,"AnnualValue":null,"CompletedWithNegotiation":false,"EuFundsUsed":false,"HighestAcceptableOfferValue":501608.10,"IsContractConcluded":false,"LegalRemediesUsed":false,"LowestAcceptableOfferValue":501608.10,"MonthlyValue":null,"NumberOfAcceptableOffers":1,"NumberOfReceivedOffers":1,"PreferentialTreatmentUsed":false,"PriorAnnouncementNumber":null,"PriorAnnouncementId":null,"ReasonsForNegotiatedProcedure":"Iz razloga koji se odnose na zaštitu ekskluzivnih prava.","RegulationQuoteId":75,"RegulationQuoteName":"Član 21. Stav (1) Tačka c)","SubcontractingShare":null,"SubcontractingShortDescription":null,"SubcontractingValue":null,"MasterAgreementEndDate":null,"MasterAgreementStartDate":null,"LastUpdated":"2023-12-21T22:11:00.6715569Z"}]}